American Journal of Clinical Psychiatry
August 2004
By Alen J. Salerian, MD
Sir: There have been numerous reports of the sexually enhancing effects of tetrahydrocannabinol (THC) (1), and this letter reports positive outcome in a female bipolar patient after dronabinol use. Dronabinol, a medication currently labeled as Schedule III, is approved by the US Food and Drug Administration [...]